DexCom (DXCM) : During the past 4 weeks, traders have been relatively bearish on DexCom (DXCM), hence the stock is down -4.3% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -6.81% relative to the S&P 500. The 4-week change in the price of the stock is -4.81% and the stock has fallen -6.66% in the past 1 week.
The stock has recorded a 20-day Moving Average of 5.54% and the 50-Day Moving Average is 4.11%.The 200 Day SMA reached 16.73%
DexCom (NASDAQ:DXCM): The stock opened in the green at $88.36 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $89.02 and a low of $86.81 for the day. The stock did not find buyers even at the lows and closed at $87.66 recording a loss of -0.16%. 1,025,933 shares exchanged hands during the trading day. The stock had closed at $87.66 in the previous days trading.
DexCom (DXCM) : The highest short term price target forecast on DexCom (DXCM) is $115 and the lowest target price is $57. A total of 14 equity analysts are currently covering the company. The average price of all the analysts is $96.7 with a standard deviation of $14.43.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.